Levetiracetam Tablet, Film Coated
Product Images NDC 16714-034

15 FDA label images from Northstar Rxllc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 16714-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000mg 60s

1000mg 60s
Label for Levetiracetam Tablets USP 1000 mg, film-coated oral tablets. The package contains 60 tablets and includes pharmacist dispensing instructions. Manufactured for Northstar Rx LLC, Memphis, TN, and produced by Hetero Labs Limited, India. The label includes storage instructions and batch coding area.*
FDA Label Image

120cont (120cont)

120cont (120cont)
Label for Levetiracetam Tablets USP 500 mg, film-coated tablets for oral use. The label shows a 120 tablet count and instructs pharmacists to dispense with medication guide provided separately. It includes storage instructions, manufacturer and distributor details, a barcode, and a pink box marked 45 x 35 mm Un Varnish Area. Labeler is NorthStar Rx LLC.*
FDA Label Image

500cont (500cont)

500cont (500cont)
Levetiracetam Tablets USP 500 mg film-coated tablets label showing a 500 count package. The label includes storage instructions, manufacturer information, and a barcode. Manufactured for NorthStar Rx LLC and by Hetero Labs Limited, India. The label also features directions for pharmacists and batch coding area.*
FDA Label Image

500mg120sannora

500mg120sannora
Levetiracetam Tablets USP 500 mg film-coated tablets label. The label states dispensing instructions for pharmacists, storage conditions, and medication guide availability. It indicates 120 tablets per package, manufactured by Annora Pharma Pvt. Ltd., India, for NorthStar Rx LLC. Includes NDC 16714-035-01 and barcode.*
FDA Label Image

Figure-of-levet1 (Figure Of Levet1)

Figure-of-levet1 (Figure Of Levet1)
Bar chart showing the percentage of patients by treatment group. The vertical axis represents the percentage of patients, ranging from 0% to 45%. Three bars compare Placebo (7.4%, N=95), Levetiracetam 1000 mg/day (37.1%, N=97), and Levetiracetam 3000 mg/day (39.6%, N=101). Percentages are labeled above each bar.*
FDA Label Image

Figure-of-levet2 (Figure Of Levet2)

Figure-of-levet2 (Figure Of Levet2)
A bar graph comparing the percentage of patients across three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day (N=105) at 35.2%. The y-axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Figure-of-levet3 (Figure Of Levet3)

Figure-of-levet3 (Figure Of Levet3)
A bar graph comparing the percentage of patients in two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percentage of patients from 0% to 45%. The Placebo group shows 14.4%, while the Levetiracetam group shows 39.4% marked with an asterisk above the bar.*
FDA Label Image

Figure-of-levet4 (Figure Of Levet4)

Figure-of-levet4 (Figure Of Levet4)
Bar chart comparing the percentage of patients for Placebo and Levetiracetam groups. The x-axis shows Placebo (N=97) and Levetiracetam (N=101). The y-axis represents percentage of patients from 0% to 45%. The Placebo bar reaches 19.6%, while the Levetiracetam bar reaches 44.6% with an asterisk mark indicating statistical significance.*
FDA Label Image

Figure-of-levet5 (Figure Of Levet5)

Figure-of-levet5 (Figure Of Levet5)
A bar graph comparing the percentage of patients between placebo (N=51) and Levetiracetam (N=58) groups. The placebo group shows 19.6% of patients, while the Levetiracetam group shows 43.1%. The y-axis represents the percentage of patients from 0% to 45%.*
FDA Label Image

Figure-of-levet6 (Figure Of Levet6)

Figure-of-levet6 (Figure Of Levet6)
A bar graph comparing the percentage of patients between two groups: Placebo (N=84) with 45.2% and Levetiracetam (N=79) with 72.2%. The y-axis represents the percentage of patients, ranging from 0% to 100%. The Levetiracetam bar is marked with an asterisk above the percentage value.*
FDA Label Image

Levestructure (Levestructure)

Levestructure (Levestructure)
Chemical structure of the active ingredient levetiracetam, showing a pyrrolidone ring attached to an ethyl group and a carbonyl-containing side chain.*
FDA Label Image

Levetablets120scountcontlabel250mg

Levetablets120scountcontlabel250mg
Levetiracetam Tablets USP 250 mg film-coated tablet label. Contains 120 tablets. Label includes storage instructions, pharmacist dispensing guidance, manufacturer details (NorthStar Rx LLC, Memphis, TN and Hetero Labs Limited, India), barcode, and batch coding area on a white and blue background.*
FDA Label Image

Levetablets120scountcontlabel750mg

Levetablets120scountcontlabel750mg
Levetiracetam Tablets USP 750 mg film-coated oral tablets packaging label showing 120 tablets. Manufactured by Hetero Labs Limited, India, for NorthStar Rx LLC. Includes pharmacist dispensing instructions, storage conditions, medication guide availability, barcode, and manufacture details.*
FDA Label Image

Levetablets500scountcontlabel250mg

Levetablets500scountcontlabel250mg
Levetiracetam Tablets, USP 250 mg film-coated tablet label by NorthStar Rx LLC. The label indicates a 500-tablet count and includes storage instructions, pharmacist dispensing guidance, manufacturer information (Hetero Labs Limited, India), and a barcode. The label also states the product is a prescription drug and provides contact information for medication guides.*
FDA Label Image

Levetablets500scountcontlabel750mg

Levetablets500scountcontlabel750mg
Levetiracetam Tablets USP 750 mg film-coated tablets label for oral use. The label indicates a package size of 500 tablets and includes storage instructions, pharmacist dispensing guidance, manufacturer details (Northstar Rx LLC and Hetero Labs Limited, India), a barcode, and contact information for medication guides. The label is primarily white with blue and pink sections, showing the NDC 16714-537-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.